Radiopharmaceuticals Market Industry Analysis and Opportunity and Forecast to 2029
Data
Bridge Market Research analyses that
the radiopharmaceuticals market is expected to undergo a CAGR of 10.40% during the
forecast period. This indicates that the market value, which was USD 4.80 billion
in 2021, would rocket up to USD 11.69 billion by 2029.
Nuclear
medicine/ radiopharmaceuticals are increasingly being used in diagnostic
imaging and radiotherapy. This has carved the way for the growth of the
radiopharmaceutical market. Nuclear medicine/ radiopharmaceuticals assist in
diagnosing the organs of any pathological condition, especially
cancer. The huge development of nuclear imaging technologies, mainly
PET/PET-CT, has helped to increase the field of uses for this modality from
oncology to cardiology, neurology, and infection detection.
Market Analysis and
Insights
WHO stated that cancer would be responsible for 10
million deaths globally in 2020. Furthermore, the American Cancer Society
states that in the U.S., in 2020, around 1,806,590 new cancer cases will be
diagnosed. As per the European Heart Network, CVDs account for around 1.8
million of Europe's 3.9 million annual deaths. In the U.S., congestive heart
failure (CHF) affected around 5 million people in 2018, as per Emory
Healthcare. Nuclear substances are used for diagnosis and examination reasons.
They are widely used in diagnostic tests such as positron emission tomography
(PET) and single-photon emission computerized tomography, essential for
treating chronic disorders (SPECT). Thus, this factor boosts market growth.
Radiopharmaceuticals Market Scope
The radiopharmaceuticals market is segmented on the
basis of type, application, procedural volume assessment, source, and end user.
The growth amongst these segments will help you analyze meagre growth segments
in the industries and provide the users with a valuable market overview and
market insights to help them make strategic decisions for identifying core
market applications.
Type
· Diagnostic Nuclear
Medicine
· SPECT
Radiopharmaceuticals
· Technetium-99m
· Thallium-201
· Gallium-67
· Iodine-123
· Other
· PET
Radiopharmaceuticals
· F-18
· RU-82
· Others
· Therapeutic Nuclear
Medicine
· Alpha Emitters
· Ra-223
· Brachytherapy
Isotopes
· Intoiodine-125
· Palladium-103
· Cesium-131
· Iridium-192
· Other brachytherapy
isotopes
· Beta Emitters
· Intoiodine-131
· Yttrium-90
· Samarium-153
· Lutetium-177
· Rhenium-186
· Other beta emitters
Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/global-radiopharmaceuticals-market
Radiopharmaceuticals Market Country
Level Analysis
The
worldwide RADIOPHARMACEUTICALS market
research report has complete overview of the market, covering various aspects
such as product definition, segmentation based on various parameters, and the
prevailing vendor landscape. Data points like down-stream and upstream value
chain analysis, technical trends and porter's five forces analysis, case
studies are some of the pointers used to forecast the market scenario for
individual countries. Also, the presence and availability of global brands and
their challenges faced due to large or scarce competition from local and
domestic brands, impact of domestic tariffs and trade routes are considered
while providing forecast analysis of the country data.
The countries covered in the nuts
market report are
· Singapore,
Malaysia, Australia,
· Thailand, Indonesia,
· Saudi Arabia,
U.A.E,
· South Africa,
Egypt,
· Israel,
· Rest of Middle
East and Africa (MEA) as a part of Middle East and Africa (MEA),
· Brazil
· U.S.,
· Canada and
Mexico in North America,
· Germany,
France,
· U.K.,
Netherlands,
· Switzerland,
Belgium,
· Russia, Italy,
· Spain, Turkey,
Rest of Europe in Europe,
· China, Japan,
· India, South
Korea,
Major TOC of
theRadiopharmaceuticals Market Report
Chapter One:
CHAPTER ONE - MARKET SEGEMENTATION
CHAPTER TWO - EXECUTIVE SUMMARY
CHAPTER THREE - PREMIUM INSIGHTS
CHAPTER FOUR - MARKET OVERVIEW
Browse The Table of Contents And
List of Figures https://www.databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
Competitive Landscape and
Radiopharmaceuticals Market Share Analysis
The
market report consists of explicit and up to date information about the
consumer’s demands, their inclinations, and their variable likings about
particular product Details included are
company overview, company financials, revenue generated, market potential,
investment in research and development, new market initiatives, global
presence, production sites and facilities, production capacities, company
strengths and weaknesses, product launch, product width and breadth,
application dominance. The above data points provided are only related to the
companies' focus related to radiopharmaceuticals market.
The major players covered in the
Radiopharmaceuticals Marketreport are
· Nordion (Canada)
· Advanced Accelerator Applications (France)
· NTP Radioisotopes (South Africa)
· JSC Isotope (Russia)
· NorthStar Medical Radioisotopes (US)
· Eckert & Ziegler (Germany)
· Zimmer Biomet (US)
· Hanger Inc. (US)
· Otto Bock Healthcare GmBH (Germany
· Lantheus Medical Imaging (US)
· Bayer AG (Germany)
· Bracco Imaging (Italy)
· Eczacýbaþý-Monrol Nuclear Products (Turkey)
· Braun Melsungen AG (Germany)
· Smith & Nephew plc (Germany)
Browse Related Reports @
Middle
East and Africa Ethylene-Vinyl Alcohol Copolymer (EVOH) Packaging Films Market
Global
Commercial Dishwashers Market
Global
Private Label Food and Beverage Market
Global
Topical Corticosteroids Market
Europe
Point of Care Testing (POCT) Device Market
Europe
Point-Of-Care-Testing (POCT) Market
Europe
Sports Management Software Market
About
Us:
Data Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting firm with
unparalleled level of resilience and integrated approaches. We are determined
to unearth the best Market opportunities and foster efficient information for
your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-3895-2818
Comments
Post a Comment